Someone has put a lot of faith in Weight Watchers.
Media mogul Oprah Winfrey reportedly bought a 10 percent stake in the dieting company. Reuters said that the Oprah Winfrey Network (OWN) CEO bought 6.4 million of Weight Watchers’ shares at Friday’s closing price of USD6.79 per share. USA Today wrote that aside from the sizeable USD43.2 million stake, she is expected to get options that would allow her to acquire an additional 5 percent in the company. As a result of her recent investment, she is set to sit in the company’s board.
On the company’s official Facebook page, Weight Watchers announced, "We're thrilled to share some big news today- Oprah Winfrey has joined our Board and is a part owner of Weight Watchers! She's a Member on her own personal journey toward success, and she believes so much in what we do and our mission that she wants to work with us to inspire people around the world to lead healthier and more fulfilling lives. We are thrilled to count one of the world's most inspiring women among our #WWFamily and are so excited for what the future holds! "O" it's an exciting day!"
Shares of the dieting company soared 89.9 percent in pre-market trading on Monday due to the news, Forbes observed.


Chevron Sees Path to Boost Venezuela Oil Output by 50% After Trump Administration Talks
OpenAI Sets $50 Billion Stock Grant Pool, Boosting Employee Equity and Valuation Outlook
Samsung Forecasts Strong Q4 Profit on AI-Driven Memory Chip Boom
xAI Cash Burn Highlights the High Cost of Competing in Generative AI
Boeing 737 MAX 10 Advances in FAA Testing as Certification Delays Continue
Stellantis to End Plug-In Hybrid Sales in the U.S. as Demand Shifts Toward Traditional Hybrids
AustralianSuper Backs BlueScope Steel’s Rejection of $9 Billion Takeover Bid
UBS Upgrades L’Oréal to Buy, Sees Strong Sales Momentum and 20% Upside
Supreme Court to Hear Cisco Appeal on Alien Tort Statute and Human Rights Liability
BlueScope Steel Shares Slip After Board Rejects A$13.2 Billion Takeover Bid
Johnson & Johnson Secures Tariff Exemption by Agreeing to Lower Drug Prices in the U.S.
Federal Appeals Court Blocks Trump-Era Hospital Drug Rebate Plan
FTC Blocks Edwards Lifesciences’ JenaValve Acquisition in Major Antitrust Ruling
FCC Exempts Select Foreign-Made Drones From U.S. Import Ban Until 2026
Ford Targets Level 3 Autonomous Driving by 2028 with New EV Platform and AI Innovations
Aktis Oncology Prices Upsized IPO at $18, Raising $318 Million in Major Biotech Debut
Hyundai Motor Shares Surge on Nvidia Partnership Speculation 



